Mirum Pharmaceuticals, Inc. (MIRM): Total Assets
$842.81M
As of 2025-12-31
$1.04B
As of 2026-06-30
+33.7%
3-year compound annual growth
+28.5%
5-year compound annual growth
| Period ended | Total Assets | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $842.81M | +25.7% | 2026-02-25, Balance as of period end |
| 2024-12-31 | $670.75M | +3.7% | 2026-02-25, Balance as of period end |
| 2023-12-31 | $646.62M | +83.2% | 2025-02-26, Balance as of period end |
| 2022-12-31 | $352.91M | +19.8% | 2024-03-15, Balance as of period end |
| 2021-12-31 | $294.65M | +22.3% | 2023-03-08, Balance as of period end |
| 2020-12-31 | $240.86M | +64.2% | 2022-03-09, Balance as of period end |
| 2019-12-31 | $146.71M | +182.3% | 2021-03-09, Balance as of period end |
| 2018-12-31 | $51.98M | n/a | 2020-03-12, Balance as of period end |
Total Assets at similar companies
| Company | Year ended | Total Assets | Change YoY |
|---|---|---|---|
| Mirum Pharmaceuticals, Inc. (MIRM) | 2025-12-31 | $842.81M | +25.7% |
| BridgeBio Pharma, Inc. (BBIO) | 2025-12-31 | $936.02M | +1.8% |
| HUTCHMED (China) Ltd (HCM) | 2025-12-31 | $1.75B | +37.6% |
| Travere Therapeutics, Inc. (TVTX) | 2025-12-31 | $605.19M | +1.9% |
| Organogenesis Holdings Inc. (ORGO) | 2025-12-31 | $598.73M | +20.3% |
| Nature's Sunshine Products Inc (NATR) | 2025-12-31 | $261.15M | +8.4% |
| Zai Lab Ltd (ZLAB) | 2025-12-31 | $1.17B | -1.1% |
| Insmed Inc (INSM) | 2025-12-31 | $2.26B | +11.8% |
| Opko Health, Inc. (OPK) | 2025-12-31 | $1.93B | -12.2% |
Compare MIRM, BBIO, HCM, TVTX side by side · Screen every company in Pharmaceutical Preparations ↗